Rayno Life Sciences Tools and Diagnostics: Alere, Cepheid, Quidel and Response Genetics
All of these stocks are already on our focus list but lately have shown signs of strength.
Cepheid (CPHD) has been added as a new long term buy at $31.5.
Quidel has two news items and recent strength:
Jack Schuler has added positions to 15.3% and the Flu season has an early start.
Response Genetics (RGDX) has made a big move above base of $1.10:
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.